Pfizer
PFE
2,915 hedge funds and large institutions have $109B invested in Pfizer in 2024 Q3 according to their latest regulatory filings, with 191 funds opening new positions, 1,245 increasing their positions, 1,201 reducing their positions, and 124 closing their positions.
54% more first-time investments, than exits
New positions opened: 191 | Existing positions closed: 124
27% more funds holding in top 10
Funds holding in top 10: 33 → 42 (+9)
1% more funds holding
Funds holding: 2,879 → 2,915 (+36)
4% more capital invested
Capital invested by funds: $105B → $109B (+$4.1B)
4% more repeat investments, than reductions
Existing positions increased: 1,245 | Existing positions reduced: 1,201
0.3% more ownership
Funds ownership: 66.08% → 66.38% (+0.3%)
38% less call options, than puts
Call options by funds: $2.51B | Put options by funds: $4.05B
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BNP Paribas Financial Markets
Paris,
France
|
+$425M |
| 2 |
Charles Schwab
San Francisco,
California
|
+$375M |
| 3 |
Barclays
London,
United Kingdom
|
+$345M |
| 4 |
BlackRock
New York
|
+$339M |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$286M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Capital World Investors
Los Angeles,
California
|
-$1.01B |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$360M |
| 3 |
Goldman Sachs
New York
|
-$265M |
| 4 |
Franklin Resources
San Mateo,
California
|
-$262M |
| 5 |
DCP
D1 Capital Partners
New York
|
-$213M |
PFE Hedge Fund Activity: Q3 2024 in Review
2,915 of the 6,978 institutional investors tracked by Wall St. Rank reported a position in Pfizer (PFE) for Q3 2024, worth a combined $109B — up 3.9% from $105B a quarter earlier.
Buyers outnumbered sellers: 191 funds opened new PFE positions and 124 closed out — a net gain of 67 holders — while 1,245 added to existing stakes and 1,201 trimmed.
The largest buyer was BNP Paribas Financial Markets, adding an estimated $425M. The largest seller was Capital World Investors, cutting an estimated $1.01B.
- 2,915 institutional investors held Pfizer (PFE) as of Q3 2024, up from 2,879 in Q2 2024.
- Funds reported $109B of Pfizer stock for Q3 2024, up 3.9% quarter-over-quarter.
- 191 funds opened new Pfizer positions in Q3 2024 and 124 closed out, a net change of +67 holders.
- The largest Pfizer buyer in Q3 2024 was BNP Paribas Financial Markets, an estimated $425M added.
- The largest Pfizer seller in Q3 2024 was Capital World Investors, an estimated $1.01B sold.
Based on aggregated 13F filings for Q3 2024.